Results 111 to 120 of about 45,170 (249)

Partial splenic artery embolization: an alternative management strategy for resistant thrombocytopenia of immune thrombocytopenic purpura (ITP)

Sri Lanka Journal of Medicine, 2018
A 69-year-old male presented with haematuria due to a recurrent carcinoma of the bladder in the background of resistant thrombocytopaenia with immune thrombocytopenic purpura.
L. K. Dissanayake, P. B. Hewavithana, R. M. P. Manel Rathnayake, A. U. B. Pethiyagoda   +3 more
doaj   +1 more source

Interstitial lung disease (ILD) and severe ITP

, 2007
Introduction: Platelets play an important role in inflammatory and immune responses. We report interstitial lung disease (ILD) developing during the acute phase of severe thrombocytopenia in 3 patients with severe refractory ITP.
Ahn, Yeon S, Fontana, Vincenzo, Donna, Elio, Horstman, Lawrence L, Dudkiewicz, Pamela, Ahn, Eugene R   +5 more
core   +1 more source

Türkiye’nin Güneydoğu’sundaki İTP olgularının özellikleri

, 2013
Akut immun trombositopenik purpura trombositopeni, spontan purpura, ekimoz, peteşi ve mukozal kanamalar ile karakterizedir. Trombositopeninin diğer nedenlerinin dışlanması ile tanı konur.
Söker, Murat, Yolbaş, İlyas, Güneş, Ali, Özel, Hülya, Kelekçi, Selvi, Şen, Vedat, Akyüz, Feride Çeliker   +6 more
core   +1 more source

Estandarización de las inspecciones de los proveedores de ITP Aero

The objective of this work will be to analyse how the aeronautical industry is able to implement a reduction of inspections on the engine pieces without affecting the final quality of the final piece, to reduce as much as possible the costs related to ...
Merino Gomez, Jon
core   +1 more source

Avatrombopag in immune thrombocytopenia: A real-world study of the Spanish ITP Group (GEPTI)

Avatrombopag is the newest thrombopoietin receptor agonist (TPO-RA) approved to treat immune thrombocytopenia (ITP). Real-world evidence regarding effectiveness/safety is limited.
Sánchez González, Blanca, Spanish ITP Group (GEPTI) of the Spanish Society of Hematology and Hemotherapy (SEHH), Pascual-Izquierdo, Cristina   +2 more
core   +1 more source

Measuring Interactional Competence in a Japanese University EFL Speaking Context

International Journal of Applied Linguistics, EarlyView.
ABSTRACT The ability to interact is an integral aspect of speaking proficiency. Therefore, methods of assessing interaction need to be incorporated into second language (L2) speaking tests. The main purpose of this exploratory study is to attempt to quantify interactional competence (IC) in a Japanese university EFL (English as a foreign language ...
Paul Garside
wiley   +1 more source

Thrombocytopenia in Pregnancy: A 5‐Year Analysis of Characteristics and Practices From a Tertiary Academic Center

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Background Moderate‐to‐severe thrombocytopenia (platelet count < 100 × 109/L) occurs in fewer than 1% of pregnancies, posing management challenges, particularly surrounding eligibility for neuraxial anesthesia. Although recent anesthesia guidelines recommend a platelet threshold ≥ 70 × 109/L, outcomes data applying these recommendations in ...
Mackenzie E. Lemieux, Ming Y. Lim
wiley   +1 more source

Avatrombopag for the Treatment of Adult Patients with Chronic Immune Thrombocytopenia (cITP): Focus on Patient Selection and Perspectives

Therapeutics and Clinical Risk Management, 2022
Galina Tsykunova,1– 3 Waleed Ghanima2– 4 1Department of Hematology, Haukeland University Hospital, Bergen, Norway; 2Institute of Clinical Medicine, University of Oslo, Oslo, Norway; 3Department of Hemato-Oncology, Østfold Hospital, Grålum, Norway ...
Tsykunova G, Ghanima W
doaj  

ITP of chitosan

, 2019
ITP file of chitosan using SwissParam and charges from gbasis MINI for free energy calculations in ...
Ricardo Stefani (5701472), Isabelle Caroline A. Silva Aguiar (5701592)   +1 more
core   +1 more source

Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry

, 2019
Background Romiplostim is a thrombopoietin‐mimetic peptibody for adult refractory chronic immune thrombocytopenia (ITP). We aimed to describe ITP patients receiving romiplostim, platelet counts and romiplostim usage in UK clinical practice.
Nandigam, R, Seesaghur, A, Doobaree, IU, Patel, H, Wetten, S, Mensah, L, Provan, D   +6 more
core   +4 more sources